ArticleBlood advances2020

Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736.

Andrew S Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.